88711676 - ESSENCA

Information

• Trademark
• 88711676

• Source

• Serial Number

  88711676

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 44 - Medical services

• Filing Date

  December 02, 2019
  5 years ago

• Transaction Date

  February 05, 2024
  12 months ago

• Status Date

  December 12, 2022
  2 years ago

• Published for Opposition Date

  September 15, 2020
  4 years ago

• Location Date

  November 10, 2020
  4 years ago

• Status Code

  606

• Current Location

  INTENT TO USE SECTION

  Employee Name

  VERHOSEK, WILLIAM T

• Attorney Docket Number

  ESX-T121

  Attorney Name

  Julian D. Gonzalez

  Law Office Assigned Location Code

  M50

• Owners

  • Essenlix Corporation

Case File Statements

• GS0051: Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances examined in bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medicines for medical and veterinary purposes for cancers, blood abnormalities, immune disease, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical diagnostic reagents and assays for testing bodily fluids for the prevention of disease in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic reagents and assays for testing bodily fluids for monitoring and testing illnesses and disorders in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases
• PM0001: ESSENCE
• GS0011: Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, and diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use
• TR0010: The wording "ESSENCA" has no meaning in a foreign language.
• GS0441: Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Nutrition counseling; Healthcare services in the field of digital healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the nature of providing information in the fields of health and wellness; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes; Health monitoring services, namely, monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Disease prevention services, namely, medical screening and testing services for preventing diseases in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical and healthcare services for monitoring and testing illnesses and disorders in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases
• GS0101: Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and health monitoring devices that detect health conditions and diseases in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids in the nature of biological and chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, nucleic acids, and nucleotides for the prevention of disease in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases

Case File Event Statements

• 12/12/2022 - 2 years ago

  36 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6

• 12/12/2022 - 2 years ago

  35 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6

• 5/26/2022 - 2 years ago

  34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/25/2022 - 2 years ago

  33 - SOU EXTENSION 3 GRANTED Type: EX3G

• 5/10/2022 - 2 years ago

  32 - SOU EXTENSION 3 FILED Type: EXT3

• 5/24/2022 - 2 years ago

  31 - NOTICE OF REVIVAL - E-MAILED Type: NREV

• 5/23/2022 - 2 years ago

  30 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 5/23/2022 - 2 years ago

  29 - PETITION TO REVIVE-GRANTED Type: PETG

• 5/23/2022 - 2 years ago

  28 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 1/14/2022 - 3 years ago

  27 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 1/13/2022 - 3 years ago

  26 - SOU EXTENSION 2 GRANTED Type: EX2G

• 11/10/2021 - 3 years ago

  25 - SOU EXTENSION 2 FILED Type: EXT2

• 1/11/2022 - 3 years ago

  24 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 11/16/2021 - 3 years ago

  23 - NOTICE OF REVIVAL - E-MAILED Type: NREV

• 11/16/2021 - 3 years ago

  22 - SOU EXTENSION RECEIVED WITH TEAS PETITION Type: TPEX

• 11/16/2021 - 3 years ago

  21 - PETITION TO REVIVE-GRANTED Type: PETG

• 11/16/2021 - 3 years ago

  20 - TEAS PETITION TO REVIVE RECEIVED Type: PROA

• 5/11/2021 - 3 years ago

  19 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 5/7/2021 - 3 years ago

  18 - SOU EXTENSION 1 GRANTED Type: EX1G

• 5/7/2021 - 3 years ago

  17 - SOU EXTENSION 1 FILED Type: EXT1

• 5/7/2021 - 3 years ago

  16 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 11/10/2020 - 4 years ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 9/15/2020 - 4 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/15/2020 - 4 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/26/2020 - 4 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/13/2020 - 4 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/11/2020 - 4 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/11/2020 - 4 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/9/2020 - 4 years ago

  8 - ASSIGNED TO LIE Type: ALIE

• 7/22/2020 - 4 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/22/2020 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 1/22/2020 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/22/2020 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/14/2020 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 12/6/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/5/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP